Market Place
Sourcing Support
Stuart Therapeutics, Inc. Announces Key Addition to its Executive Team
25 Jul 2024 //
PR NEWSWIRE
Stuart Therapeutics Appoints Dr. Lukas Scheibler As Chief Science Officer
25 Jul 2024 //
CONTRACT PHARMA
Stuart Announces First Patient, First Visit in Phase 3 Trial of Vezocolmitide
29 Dec 2023 //
PR NEWSWIRE
Stuart Therapeutics Announces Exclusive Worldwide License Agreement with Glaukos
18 Oct 2023 //
PR NEWSWIRE
Stuart Announces Issuance of Patent Covering Ophthalmic Segment Disorders
08 Sep 2023 //
PR NEWSWIRE
Stuart announces, expansion of development pipeline, additions to Advisory Board
09 Jan 2023 //
PR NEWSWIRE
Stuart Therapeutics, Inc. announces licensing agreement with Aju Pharm Co. Ltd.
03 Jan 2023 //
PR NEWSWIRE
Stuart Tx Announces Important Additions to the Company`s IP portfolio
22 Jul 2022 //
PRNEWSWIRE
Stuart Therapeutics Announces Successful Outcome from Type C Meeting with FDA
18 Jul 2022 //
PRNEWSWIRE
Stuart Announces Successful Phase 2 Results of Dry Eye Candidate, ST-100
03 Jan 2022 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.